Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Meropenem
Drug ID BADD_D01393
Description Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death. In August 2017, a combination antibacterial therapy under the market name vabomere was approved for treatment of adult patients with complicated urinary tract infections (cUTI). Vabomere consists of meropenem and [DB12107] and is intravenously admininstered. The treatment aims to resolve infection-related symptoms and achieve negative urine culture, where the infections are proven or strongly suspected to be caused by susceptible bacteria.
Indications and Usage For use as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: complicated skin and skin structure infections due to Staphylococcus aureus (b-lactamase and non-b-lactamase producing, methicillin-susceptible isolates only), Streptococcus pyogenes, Streptococcus agalactiae, viridans group streptococci, Enterococcus faecalis (excluding vancomycin-resistant isolates), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Bacteroides fragilis and Peptostreptococcus species; complicated appendicitis and peritonitis caused by viridans group streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacteroides fragilis, B. thetaiotaomicron, and Peptostreptococcus species. Also for use in the treatment of bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (b-lactamase and non-b-lactamase-producing isolates), and Neisseria meningitidis.
Marketing Status Prescription; Discontinued
ATC Code J01DH02
DrugBank ID DB00760
KEGG ID D02222
MeSH ID D000077731
PubChem ID 441130
TTD Drug ID D0O5FY
NDC Product Code 44567-146; 38217-0021; 70594-075; 72572-415; 70121-1453; 44567-401; 0781-3000; 70278-104; 0409-1390; 63323-508; 63323-507; 70594-076; 70121-1454; 70278-103; 0409-1391; 68083-146; 55150-208; 72572-416; 44647-032; 44567-145; 0781-3098; 52946-0839; 44567-400; 44647-033; 55150-207; 68001-324; 0069-0314; 38217-0020; 68083-147; 68001-447; 68001-323; 68001-446
Synonyms Meropenem | 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid | Merrem | Ronem | Penem | SM 7338 | SM-7338 | SM7338
Chemical Information
Molecular Formula C17H25N3O5S
CAS Registry Number 96036-03-2
SMILES CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rash23.03.13.0010.003300%Not Available
Rash erythematous23.03.06.0030.000319%Not Available
Rash generalised23.03.13.0020.000213%Not Available
Rash macular23.03.13.0030.000319%Not Available
Red blood cells urine positive13.13.02.003--Not Available
Renal failure20.01.03.0050.000222%Not Available
Respiratory disorder22.02.07.002--Not Available
Respiratory distress22.02.01.0120.000213%Not Available
Respiratory failure22.02.06.002; 14.01.04.0030.000194%
Restlessness19.11.02.002; 17.02.05.0210.000213%
Rhabdomyolysis15.05.05.0020.000213%
Seizure17.12.03.0010.002661%
Sepsis11.01.11.0030.000305%
Septic shock11.01.11.004; 24.06.02.0110.000666%Not Available
Shock24.06.02.0020.000056%Not Available
Skin disorder23.03.03.007--Not Available
Skin exfoliation23.03.07.0030.000532%Not Available
Skin ulcer24.04.03.007; 23.07.03.003--
Somnolence19.02.05.003; 17.02.04.006--
Stevens-Johnson syndrome11.07.01.005; 10.01.03.020; 23.03.01.007; 12.03.01.0140.000213%
Syncope24.06.02.012; 17.02.04.008; 02.01.02.008--
Systemic candida11.03.03.0160.000139%Not Available
Tachycardia02.03.02.0070.000532%Not Available
Tenderness08.01.08.0050.000213%Not Available
Tension19.06.02.005--Not Available
Thrombocytopenia01.08.01.0020.001597%Not Available
Thrombocytosis01.08.02.001--Not Available
Thrombophlebitis24.01.02.001--Not Available
Thrombosis24.01.01.006--Not Available
Toxic encephalopathy17.13.01.004; 12.03.01.0270.000213%Not Available
The 8th Page    First    Pre   8 9 10 11    Next   Last    Total 11 Pages